Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tikun Hemp is the hemp-derived CBD division of Tikun Olam, a global pioneer in medical cannabis research and development. The company translates over 15 years of clinical data and proprietary genetics from Israel into a line of premium, broad-spectrum hemp products for the US market. Their offerings are centered around specific, well-researched strains such as Avidekel, which is known for its high CBD content and therapeutic efficacy. Tikun Hemp focuses on providing science-based solutions for conditions including inflammation, anxiety, and sleep disorders. The brand emphasizes rigorous testing and "seed-to-shelf" traceability to ensure product safety and consistency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tikun Hemp.